Sensient Technologies Corporation's Color Group revenue rose 17% in local currency, driven mainly by higher volumes of natural colors. Management aims to achieve an additional $1 billion in annual natural color revenue by the end of 2028, signaling strong growth potential. However, customer reformulations and gradual product rollouts may delay full revenue benefits. Despite growth, heavy capital spending has led to a negative free cash flow of about $30.5 million over nine months, and the stock remains expensive, leading to a Hold rating.
Sensient Technologies is noted here with its valuation concerns, while Pluang's Basic Materials sector shows strong market breadth. For readers following Basic Materials, here is Pluang's market snapshot as of Nov 02, 2026 22:13 WIB: out of 83 priced US stocks, 78 rose and 5 fell. Notable gainers include CDE at USD 13.73 (+4.93%), PAAS at USD 39.76 (+4.69%), and ARIS at USD 15.08 (+4.61%).
The global bio-based construction polymer market, valued at $18.2 billion in 2025, is projected to grow to $35 billion by 2033 at an 8.3% CAGR. Growth is fueled by rising demand for sustainable building materials that reduce greenhouse gas emissions ...
Annual Over-the-Air (OTA) software updates for software-defined vehicles (SDVs) are projected to reach over 2 billion globally by 2035, up from 546 million in 2025, driven by rising SDV sales and advanced vehicle software platforms. Level 3 and above...
Fram Wind Solutions AS, a joint venture partly owned by BW Offshore, secured a NOK 1.94 billion grant from Enova to develop a floating offshore wind project featuring two 18.5 MW turbines, the largest globally, with a combined capacity of 37 MW. The ...
Thailand's textile market is projected to grow from USD 4.97 billion in 2026 to USD 5.39 billion by 2032, at a CAGR of 1.31%. Growth is fueled by domestic fiber production, machinery upgrades, and rising demand for faster garment replenishment, espec...
Callan JMB has received and will install a QuickStrip™ oral thin-film production line from Rapid Dose Therapeutics at its Texas facility, marking a key step in expanding its domestic pharmaceutical manufacturing. This new capability aims to produce f...
